Skip to main content

About the NCI Council of Research Advocates

NCRA members with NCI Deputy Director Dr. Douglas Lowy.

Credit: National Cancer Institute

The Office of Advocacy Relations (OAR) manages the NCI Council of Research Advocates (NCRA), the only federal advisory committee comprised solely of advocate leaders at NCI. NCRA  convenes around broad cancer research issues and provides the Director with advice and strategic insights from the community's perspective.

NCRA members are selected for their expert knowledge of cancer research and policy, as well as their ability to represent a broad patient perspective.

Prior NCRA meeting agendas and summaries can be found through the NCI Division of Extramural Activities.

Chair

Dr. Greg Aune
2019
Assistant Professor of Pediatrics
University of Texas Health Science Center at San Antonio
San Antonio, TX

Members

Mr. Rick Bangs
2020
Chair
SWOG Patient Advocate Committee
Rochester Hills, MI
Ms. Mary Ann Battles
2019
Head, Clinical Quality and Compliance
Genentech
South San Francisco, CA

Ms. Julie Fleshman
2020
President and CEO
Pancreatic Cancer Action Network (PanCAN)
Manhattan Beach, CA

Ms. Sue Friedman
2019
Executive Director
Facing Our Risk of Cancer Empowered
Tampa, FL
Ms. Danielle Leach
2020
Senior Director of Government Relations and Advocacy
St. Baldrick's Foundation | Conquer Childhood Cancers
Huntington, MD
Mr. Roberto Vargas
2019
Navigator, Community Engagement and Health Policy Program
Clinical & Translational Science Institute, University of California, San Francisco
San Francisco, CA

 

  • Updated: